Guest guest Posted April 3, 2011 Report Share Posted April 3, 2011 April 4, 2011 HCV » April Newsletter » HCV Fact Sheets » Educational Materials » HCSP Streaming Videos Greetings: This week's postings include:Top News from EASL 2011: Here are a few highlights: Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment. FDA Fast Track designations granted for both the protease inhibitor BI 201335 plus standard-of-care and the interferon-free combination of BI 201335 with polymerase inhibitor, BI 207127. PegIFN-lambda shows superior virological response and improved safety than PegIFN-alpha-2a. First Vaccine For Viral Hepatitis C Could Become A Reality. April 2011 HCV Advocate newsletter that includes: Why We Should Test-Editorial: Testing everyone for HCV regardless of medical coverage is a very contentious issue, Now that we will have new response-guided treatment regimens and rapid testing, it may be time to take another look. HCV Snapshots this month is a pot pourri of interesting items from Silibinin monotherapy to IL28B Genomic-based Treatment Paradigms. Liver Transplantation: HCV Recurrence and Treatment, by Liz Highleyman, is a must read. HEALTHWISE: Humor, Health, and Hepatitis C is yet another delightful essay, by Lucinda K. Porter, RN., on living with hepatitis C. April HBV Journal Review that includes: Rate of HBV drops in the U.S. Screening All Chemotherapy Patients for Hepatitis B. Connections between Hepatitis B and Diabetes. Biopsy and Treatment Recommended in HBeAg-negative Patients. Immunization at Birth Reduces Infection, but Parents May Still Transmit Infection. HIV-HBV Coinfected Face Higher Death Rates than HIV-HCV Coinfected. ...and more New Hepatitis & Tattos Blog: Be sure to check out and participate in our new blog. Don't forget to check out our HCV & HBV Advocate Hepatitis Blog for more about the most recent news stories. Sincerely,Alan Join me on Twitter - . Alan Franciscus Executive Director, Hepatitis C Support Project Editor-in-Chief, HCV Advocate www.hcvadvocate.org Editor-in-Chief, HBV Advocate www.hbvadvocate.org . **Questions and Comments: If you have questions or comments please do not reply to this email. Questions and/or comments can be directed to alanfranciscus@... .. HBV » HBV Journal Review » HBV Factsheets » HBV & HCV Advocate Hepatitis Blog » Stay connected with all the late-breaking news on hepatitis B-Join us on Twitter Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.